Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Valyon

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Orvosi Hetilap|January 11, 1976
[The incidence of hyperlipoproteniema and distribution of types in the patient material of a hospital department of internal medicine]G Pados, D Kusztos, M Valyon
Orvosi Hetilap|May 26, 1974
[Carbohydrate-induced hyperlipemic crisis]G Pados, D Kusztos, M Valyon
Orvosi Hetilap|June 18, 1978
[Difficulties in typing hyperlipoproteinemias]G Pados, D Kusztos, M Valyon
Acta Biologica Hungarica|January 1, 1993
The diagnostic significance of autoantibodies against cartilage components or their counterparts in destructive articular diseasesM Németh-Csóka, M Valyon, C Paróczai
The Journal of Biological Chemistry|August 15, 1993
Expression of alternatively spliced epidermal growth factor-like domains in aggrecans of different species. Evidence for a novel moduleC Fülöp, E Walcz, M Valyon, et al.
The European Respiratory Journal|February 2, 2008
Environmental temperature and relative humidity influence exhaled breath condensate pHT Kullmann, I Barta, B Antus, et al.
Przeglad Lekarski|January 1, 1989
The clinical diagnostic significance of the investigation of receptor mediated pathway of LDLM Németh-Csóka, M Valyon, K Halasy, et al.
Orvosi Hetilap|February 17, 1980
[Significance of the alpha lipoprotein-cholesterol level in healthy subjects and patients with myocardial infarct]G Pados, D Kusztos, M Valyon, et al.
Therapia Hungarica (English Edition)|January 1, 1983
Favourable effect of combined Miscleron-Xavin treatment on HDL-cholesterol levelG Pados, D Kusztos, M Németh-Csóka, et al.
Orvosi Hetilap|June 3, 1979
[Lipid studies in patients with myocardial infarct, arteriosclerosis obliterans and diabetes mellitus]G Pados, D Kusztos, M Valyon, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Orvosi Hetilap|January 11, 1976
[The incidence of hyperlipoproteniema and distribution of types in the patient material of a hospital department of internal medicine]G Pados, D Kusztos, M Valyon
Orvosi Hetilap|May 26, 1974
[Carbohydrate-induced hyperlipemic crisis]G Pados, D Kusztos, M Valyon
Orvosi Hetilap|June 18, 1978
[Difficulties in typing hyperlipoproteinemias]G Pados, D Kusztos, M Valyon
Acta Biologica Hungarica|January 1, 1993
The diagnostic significance of autoantibodies against cartilage components or their counterparts in destructive articular diseasesM Németh-Csóka, M Valyon, C Paróczai
The Journal of Biological Chemistry|August 15, 1993
Expression of alternatively spliced epidermal growth factor-like domains in aggrecans of different species. Evidence for a novel moduleC Fülöp, E Walcz, M Valyon, et al.
The European Respiratory Journal|February 2, 2008
Environmental temperature and relative humidity influence exhaled breath condensate pHT Kullmann, I Barta, B Antus, et al.
Przeglad Lekarski|January 1, 1989
The clinical diagnostic significance of the investigation of receptor mediated pathway of LDLM Németh-Csóka, M Valyon, K Halasy, et al.
Orvosi Hetilap|February 17, 1980
[Significance of the alpha lipoprotein-cholesterol level in healthy subjects and patients with myocardial infarct]G Pados, D Kusztos, M Valyon, et al.
Therapia Hungarica (English Edition)|January 1, 1983
Favourable effect of combined Miscleron-Xavin treatment on HDL-cholesterol levelG Pados, D Kusztos, M Németh-Csóka, et al.
Orvosi Hetilap|June 3, 1979
[Lipid studies in patients with myocardial infarct, arteriosclerosis obliterans and diabetes mellitus]G Pados, D Kusztos, M Valyon, et al.
Pageof 2